» Articles » PMID: 37090161

Berberine Disrupts Staphylococcal Proton Motive Force to Cause Potent Anti-staphylococcal Effects

Overview
Journal Biofilm
Date 2023 Apr 24
PMID 37090161
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of antibiotic resistance has increased the urgency for more effective treatments of bacterial infections. Biofilm formation has complicated this issue as biofilm bacteria become tolerant to antibiotics due to environmental factors such as nutrient deprivation and adhesion. In septic arthritis, a disease with an 11% mortality rate, bacteria in synovial fluid organize into floating, protein-rich, bacterial aggregates (mm-cm) that display depressed metabolism and antibiotic tolerance. In this study, (), which is the most common pathogen in septic arthritis, was tested against different inhibitors that modulate bacterial surface protein availability and that should decrease bacterial aggregation. One of these, berberine, a quaternary ammonium compound, was found to reduce bacterial counts by 3-7 logs in human synovial fluid (aggregating medium) with no effect in tryptic soy broth (TSB, non-aggregating). Unlike traditional antibiotics, the bactericidal activity of berberine appeared to be independent of bacterial metabolism. To elucidate the mechanism, we used synovial fluid fractionation, targeted MRSA transposon insertion mutants, dyes to assess changes in membrane potential (DiSC(5)) and membrane permeability (propidium iodide (PI)), colony counting, and fluorescence spectroscopy. We showed that berberine's activity was dependent on an alkaline pH and berberine killed both methicillin-sensitive and MRSA in alkaline media (pH 8.5-9.0; p < 0.0001 vs. same pH controls). Under these alkaline conditions, berberine localized to where berberine was isolated in cytoplasmic (∼95%) and DNA (∼5%) fractions. Importantly, berberine increased bacterial cell membrane permeability, and disrupted the proton motive force, suggesting a mechanism whereby it may be able to synergize with other antibacterial compounds under less harsh conditions. We suggest that berberine, which is cheap and readily available, can be made into an effective treatment.

Citing Articles

New Insights in Natural Bioactive Compounds for Periodontal Disease: Advanced Molecular Mechanisms and Therapeutic Potential.

Hashim N, Babiker R, Chaitanya N, Mohammed R, Priya S, Padmanabhan V Molecules. 2025; 30(4).

PMID: 40005119 PMC: 11858609. DOI: 10.3390/molecules30040807.


Repurposing pinaverium bromide against Staphylococcus and its biofilms with new mechanisms.

Pengfei S, Yifan Y, Shasha L, Shaowei G, Guanqing H, Dan X AMB Express. 2024; 14(1):141.

PMID: 39718732 PMC: 11668715. DOI: 10.1186/s13568-024-01809-x.


in the treatment of depression: a comprehensive review and perspectives.

Wang Z, Wang X, Mou X, Wang C, Sun Y, Wang J Front Pharmacol. 2024; 15:1471307.

PMID: 39539631 PMC: 11557470. DOI: 10.3389/fphar.2024.1471307.


Berberine Inhibits the Inflammatory Response Induced by Isolated from Atopic Eczema Patients via the TNF-α/Inflammation/RAGE Pathways.

Maskey A, Kopulos D, Kwan M, Reyes N, Figueroa C, Mo X Cells. 2024; 13(19.

PMID: 39404402 PMC: 11475634. DOI: 10.3390/cells13191639.


Substrate dependence of transport coupling and phenotype of a small multidrug resistance transporter in .

Wegrzynowicz A, Heelan W, Demas S, McLean M, Peters J, Henzler-Wildman K J Bacteriol. 2024; 206(10):e0015124.

PMID: 39258918 PMC: 11500531. DOI: 10.1128/jb.00151-24.


References
1.
Chu M, Zhang M, Liu Y, Kang J, Chu Z, Yin K . Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections. Sci Rep. 2016; 6:24748. PMC: 4840435. DOI: 10.1038/srep24748. View

2.
Chen C, Tao C, Liu Z, Lu M, Pan Q, Zheng L . A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Phytother Res. 2015; 29(11):1822-7. DOI: 10.1002/ptr.5475. View

3.
Dastgheyb S, Parvizi J, Shapiro I, Hickok N, Otto M . Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment. J Infect Dis. 2014; 211(4):641-50. PMC: 4318921. DOI: 10.1093/infdis/jiu514. View

4.
Knott S, Curry D, Zhao N, Metgud P, Dastgheyb S, Purtill C . Floating Biofilm Formation and Phenotype in Synovial Fluid Depends on Albumin, Fibrinogen, and Hyaluronic Acid. Front Microbiol. 2021; 12:655873. PMC: 8117011. DOI: 10.3389/fmicb.2021.655873. View

5.
Mathews C, Weston V, Jones A, Field M, Coakley G . Bacterial septic arthritis in adults. Lancet. 2010; 375(9717):846-55. DOI: 10.1016/S0140-6736(09)61595-6. View